Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohns disease
Conclusion
Using validated methodologies, combination therapy with vedolizumab and thiopurines was associated with lower treatment failure compared with vedolizumab monotherapy in CD but not UC across the USA and France.
Source: Gut - Category: Gastroenterology Authors: Kirchgesner, J., Desai, R. J., Schneeweiss, M. C., Beaugerie, L., Schneeweiss, S., Kim, S. C. Tags: Gut Inflammatory bowel disease Source Type: research
More News: Corticosteroid Therapy | Crohn's Disease | Databases & Libraries | France Health | Gastroenterology | Inflammatory Bowel Disease | Remicade | Study